Publications by authors named "Svetlana Zhilina-Zhilina"
Ann Transl Med
August 2023
Article Synopsis
- Immunotherapy has significantly improved treatment responses and survival rates for non-small cell lung cancer (NSCLC), establishing immune checkpoint inhibitors (ICIs) as the key treatment method.
- A systematic review of clinical trials from the inception of immunotherapy until June 2022 showed broad usage of ICIs across various treatment lines and indications, including new approaches for adjuvant and neoadjuvant therapies.
- The future of NSCLC treatment is promising, with ongoing development of new immunotherapy drugs, such as anti-LAG-3 and IDO1, which are expected to further enhance treatment options and effectiveness.
